anti-Scg3 antibody (Everglades/Protheragen)

N/A

Report date: 2025/01/26 17:59:43

Base Information

Drug Nameanti-Scg3 antibody (Everglades/Protheragen)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionSecretogranin-3 inhibitors
TargetsSecretogranin-3
Therapy Area/IndicationsAngiogenesis disorderChoroidal NeovascularizationDiabetic Retinopathy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesProtheragen Inc
China Registration ClassN/A

Develop Information

Active CompaniesEverglades Biopharma LLCProtheragen Inc
Inactive CompaniesN/A
Active IndicationsAngiogenesis disorderChoroidal NeovascularizationDiabetic Retinopathy
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A